干细胞之家 - 中国干细胞行业门户第一站
标题:
干细胞移植常用生物学词汇
[打印本页]
作者:
fellc
时间:
2008-12-27 14:20
标题:
干细胞移植常用生物学词汇
2,3-DPG:2,3-diphosphatidylglyceric acid,2,3-二磷酸甘油酸
7 \1 W* Q/ ]& D
2-CdA:2-chlorodeoxyadenosin,cladribine,2-氯去氧腺苷
5 g) [% o3 [8 B; E9 O3 j2 n
3H-TdR:tritiated thymide,氚标记胸腺嘧啶核苷
9 M# t4 A" f3 |2 w( T& N
5-Aza:5-azacytidine,5-氮(杂)胞苷
1 X: }' k/ C* w7 k1 m% f4 u( R3 c
a2-PI:a2-antiplasmin, a2-纤溶酶原抑制物
+ Y9 Q8 s$ O6 h I9 i
AA:aplastic anemia,再生障碍性贫血
! C! J; Q% e" S C ~$ F
AAV:adeno-associated virus,腺病毒相关病毒
6 F) Z9 L2 \" y/ B$ S# j6 w) F
Ab:antibody,抗体
4 G* \$ x' g' r4 ]- }5 G: h K% X
ABC:avidin-biiotin complex method, 亲和素生物素复合物法
0 M, f8 i$ O! m) {5 |- L! ~% R! _
ABMT:autologous bone marrow transplant,自体骨髓移植
$ j8 A& d) a: p& F! r
Ac:accessory cell,辅佐细胞
' e% p$ g! R7 A& E0 A- e
ACD:acid citrate dextrose,酸性枸橼酸盐葡萄糖
8 @8 p# l2 F" U* f" O7 ~+ L
ACP:acid phosphatase,酸性磷酸梅
( O8 a/ u( z2 s$ `8 E
ACTD:actinomycin D,放线菌素D
: u1 R" b3 t5 V8 B
Acute:急性的
d! ^/ e) t" B1 m6 z' F. f T* n! H
ACV:cyclovir,阿昔洛韦
& h; Q$ ^- {/ ^# z; F
Ad:adenovirus,腺病毒
8 |2 C" t1 n4 |4 {# }
AD:antigen determinant,抗原决定簇
2 E# t. x: y; Z8 A5 O0 x
ADA:adenosine deaminase,腺苷脱氨酶
- K/ |. C1 @0 b# N
ADCC:antibody-dependent cell-mediated cytotoxicity)抗体依赖细胞介导性细胞毒性
# ]) R$ Y& A( t9 W# A0 r
Adjuvant therapy:辅助治疗
' K& W& U; w/ Y K
AEL:acute erythrocytic leukemia,急性红白血病
0 @6 ?3 |- r+ ^& \1 m
AEoL:acute eosinophilic leukemia,急性嗜酸粒细胞白血病
$ L3 ?; }, a) v, H8 e" e2 H3 l
AFP:alpha fetoprotein,甲胎蛋白
1 i+ C/ a5 I2 d& y0 F& v. S( z
Ag:antigen,抗原
% ^1 b, S: _" W% C3 z D" s
aGVHD:acute graft versus host disease,急性移植物抗宿主病
" N7 R5 i" h: f7 w% r" d; K
Aid:anti-idiotype antibody,抗独特型抗体
8 b6 C" \$ Z0 G/ J
AidS:acquired immune deficiency syndrome,获得性免疫缺陷综合征
- F" b& I8 Z3 D1 m/ w
AIF:apoptosis-inducing factor,凋亡诱导因子
" K9 j# [6 D# R9 S z3 n
AIHA:autoimmune hemolytic anemia,自身免疫性溶血性贫血
4 a' f9 d7 t3 Z1 u1 n9 \* T# k5 t: y7 R
AL:acute leukemia, 急性白血病
- j5 n2 U$ S- o' y: j
ALCL:anaplastic large cell lymphoma,退行性大细胞淋巴瘤
2 i( y' O6 @7 j6 Y& t1 S# ]
ALG:antilymphocyte globulin, 抗淋巴细胞球蛋白
8 e( m6 o/ x/ ^, y
ALIP:abnormal localization of immature precursor,未成熟前体细胞异常定位
! z# G1 }. ]3 Q( i5 |9 R
ALL:acute lymphocytic leukemia,急性淋巴细胞白血病
$ E/ d( D5 `" v( F y R
Allo-BMT:allogeneic bone marrow transplantation,异基因骨髓移植
6 s3 ~1 f" U" {
Allo-PBSCT:allogeneic peripheral blood stem cell transplantation,异基因外周血干细胞移植
`9 ?5 e6 ~" W4 s' t2 Y$ ~
Allogeneic:异基因的
N" ?$ R3 m% F k; c
Allograft:异体移植物
. `& O" ]# W) w: w) \
Alopecia:脱发
) e5 C/ l7 V1 w( U* H/ W
ALP(AKP):Alkaline phosphatase,碱性磷酸酶
' |5 t% r' }" ?- x) ~3 Y5 Q+ n
AM:adhesion molecule,粘附分子
+ u' b! y; Q" {. Z/ u! H
AMKL:acute megakaryoblastic leukemia,急性巨核细胞白血病
9 ^5 m& I- |8 U; h g
AML:acute myeloid leukemia,急性髓性白血病
* D4 Q, T# M9 j$ V! u2 i5 b/ e" y
AMM:agnogenic myeloid metaplasia,特发性髓外化生
* M/ V0 b, u' |/ Y1 c1 f
ANA:antinuclear antibody,抗核抗体
0 J: m! Y z8 f3 D
Ana-LL:anaplastic large cell lymphoma,大细胞淋巴瘤
) |6 A1 v+ j/ H1 a5 V
Anaphylaxis:过敏症
: _. q2 }7 K0 N, Y/ _
; U7 N1 b3 t" g$ I1 a
ANC:absolute neutrophil count,中性粒细胞绝对值
% y |8 H7 y9 g7 d. U7 W
Anemia:贫血
q" k0 X3 k$ A$ y( O& s$ z
ANLL:acute non-lymphocytic leukemia,急性非淋巴细胞性白血病
, k. G6 h3 O9 T4 T4 U
Antibiotic:抗生素;抗生的
/ f7 ]$ G/ j$ N. [" e
Antiemetic:止吐剂,止吐药
0 @) M1 Y% Q6 X
antineoplastic drugs:抗肿瘤药物
- h6 x. d, Y P) i
Antisense:反义引物
. A' W+ T# f$ o" x/ j$ H" A
APBSCT:autologous peripheral blood stem cell transplantation,自体外周血干细胞移植
" }; w1 z4 H6 e- {: D' T
APC:antigen processing cell,抗原呈递细胞
8 C1 Y4 B1 p. n1 H0 v* H' f
Apheresis:血浆分离置换法,血液成分部分清除
1 {) Q9 c: n' O( x
APL:acute promyelocytic leukemia,急性早幼粒细胞白血病
5 ?) T# P4 A) u L- d$ z8 i( d6 i) ]
Aplasia:发育不良,成形不完全
8 z$ W/ M- N9 T; }# Q
Apoptosis:凋亡
1 h( K1 u6 `0 S* I* H; E, `
Ara-C:arabinosyl cytosine,aracytidine阿糖胞苷
7 C- n+ c( x, ~3 s6 @
ARDS:acute respiratory distress syndrome,急性呼吸窘迫综合症;AidS-related diseases艾滋病相关疾病
9 |9 a9 f; B8 R3 J- k3 g8 @
Ascites:腹水
# s) i$ P9 t; ^+ ]
ASCT:autologous stem cell transplantation,自体干细胞移植
; I" O! z; b: }' l, i0 r- S
Aspergillus:曲霉属
5 O6 n' w1 F5 f9 {( Z. r" \# Q) D* C. [
ASS:anterior superior spine,髂前上棘
3 X% f* E# J+ }+ i5 }
AT1257:nitrocaphane,消瘤芥
! X/ Z r" p& W) W9 r6 O0 X
ATG:antithymocyte globulin,抗胸腺细胞球蛋白
G! h, i& M) V( u$ X. z4 V
ATL:adult T cell leukemia/lymphoma,成人T细胞白血病/淋巴瘤
+ @5 {. Z$ v y V v5 H
ATLS:acute tumor lysis syndrome,急性肿瘤溶解综合征
; B8 n4 o# u6 M/ K' b r" r3 ?
ATRA:all-transretinoic acid,全反式维甲酸
U% s: t5 `' d" _
AUL:acute undifferentiated cell leukemia,急性未分化细胞白血病
' z/ g7 d. [; ?' Z0 P1 t. W
AuSCT: autologous stem cell transplantation,自体造血干细胞移植
; ~8 @! p# T* g6 A
Autologous:自体的
3 i/ _; Q6 ^1 w" U3 @1 P Q
Autograft:自体移植物
" I5 G$ g5 c- E( {* C3 U
Auto-BMT: autologous bone marrow transplantation,自体骨髓移植
# k7 F6 a: G' k' A" Q
β2-MG:β2-microglobulin,β2-微球蛋白
# ?/ L* m+ x, r; V( k/ B9 u7 O m
Back-up:备份
! f7 Q$ _ n+ D! I
BCNU:Carmustine,卡氮芥,卡莫司汀
! O& }$ G# I1 D4 x0 |
BCR:breakpoint cluster region,断裂点丛集区
2 R/ Z; E% ]- k4 C" W/ J
BFU-E: burst-forming unit-erythroid,早期红系集落生成细胞
1 ~1 m, L& Z/ z7 o( h9 Y
Biopsy:活检
2 O6 Q, l4 Y% y! x$ T1 C5 Z* T! l
Blast cell:原始血细胞,母细胞
3 g3 ~( ]5 f8 D2 _% L( g5 S' _; m
Blast-CFC:blast colony forming cell,原始细胞集落形成细胞
* Z9 d& M. C4 c: D
Blast crisis:原始细胞危象
- ]- D( a' k) a* n5 G% _7 L& e4 u) J
Bm:memory B lymphocyte,记忆B淋巴细胞
8 W+ Q% A5 r6 Q: d: X, A
BMG:benign monoclonal gammopathies,良性单克隆丙球蛋白病
% X" Z# q# J! h" J2 O2 A, W/ I
BMT:bone marrow transplantation,骨髓移植
) q) f1 n9 |% Y8 t' I
Bone marrow biopsy:骨髓活检
' h' z9 F O2 R( `" d* q3 ~
Bone marrow puncture:骨髓穿刺
9 t, O" w- P7 K( p- ~
Bone marrow smear:骨髓穿刺涂片
/ B2 K) g# Z+ B a8 C1 O
BRM:biological response modifier,生物应答调节剂
0 R. c4 J3 g* [" f: X" m
Bu:busulfan,白消安,马利兰
: L$ E, Y! Z ?/ G& E. U* I
Buffer:缓冲,缓冲剂,缓冲液
! |2 D0 w; ?1 D6 a6 d$ s" d% j. h
CALLA:common acute lymphocytic leukemia antigen,普通急性淋巴细胞白血病抗原
; h: b! s! E+ x
CAM:cell adhesion molecule,细胞粘附分子
* W& ]2 D x# W2 S* T3 F4 _
Candida:念珠菌属,假丝酵母属
* A5 ~) p% n8 L1 q) ~" }* b
Catheter:导管
9 B8 t2 ~6 M% P! }1 K* q9 J# i, s, }
CB:cord blood,脐带血
" c5 m+ X& S* i# d
CB1348:chlorambucil:苯丁酸氮芥
; f8 O" B5 S( Q, x9 |3 q9 G
CBC:complete blood count,全血细胞计数
% T; r" p; ^) X0 K/ F- t/ [
CBCL:cutaneous B-cell lymphoma,皮肤B细胞淋巴瘤
% L7 ~/ z* k& x* k$ @. M% h
CBSCT:cord blood stem cell transplantation,脐血干细胞移植
9 f7 J5 \1 o; C2 }
CCI:corrected count increment,校正增值计数
2 I5 P. Q5 y! {7 D; s1 Q
CCNSA:cell cycle non-specific agents,细胞周期非特异性药物
2 ~" K7 ?0 Y9 R" ^
CCNU:lomustine,洛莫司汀,环己亚硝脲
( }- N3 j; o3 B$ q0 R# a
CCR:continuous complete remission,持续完全缓解
% K* v) k0 z3 J9 [8 E
CCSA:cell cycle specific agents,细胞周期特异性药物
9 K' a1 b; ]+ j- g
CD:Castleman's disease,Castleman病
' Y) L2 }; }2 v" t
CD:cluster of differentiation,分化群
0 m$ b1 g0 U) |% V
CD3AK:CD3 activated killer,CD3激活的杀伤细胞
, [# Y1 j* z T) D* o
CDK:cyclin dependent protein kinase,周期素依赖蛋白激酶
) `1 M) y& W4 G
CEA:carcinoembryonic antigen,癌胚抗原
$ _ _# d, |! u/ E' y
CEL:chronic eosinophil leukemia,慢性嗜酸性粒细胞白血病
( G) a; B9 M, w' Z
Central line:中心静脉导管,见central venous catheter.
. K" W1 b t" Y2 o% D) _
Central venous catheter: 中心静脉导管,又叫做central line,Hickman catheter
* b) U1 N. I; s( c8 R8 u
Centrifugation:离心
' a. n/ o- W0 {; l' G( H8 O" r# t
CFC:colony-forming cell,克隆形成细胞
, g4 X5 l/ j" N! s; {8 G
CFU:colony-forming unit,集落形成单位
0 I/ Q a4 G' \
CFU-Blast:colony-forming unit-Blast,原始集落生成细胞
. s3 _' l: T- S( l; m
CFU-E:colony-forming unit-erythroid,红系集落生成细胞
6 G1 a4 [9 h+ X, p
CFU-G:colony-forming unit-granulocyte,粒系集落生成细胞
. K. }+ m% L6 T* N$ u
CFU-GM:colony-forming unit-granulocyte/macrophage,粒单系集落生成细胞
: w2 A; k4 m! G; @; x1 v
CFU-L:colony-forming unit-leukemia,白血病细胞集落生成单位
! V" {0 g% }" \* P0 E" ]5 Q
CFU-MEG:colony-forming unit-megakaryocyte巨核系集落生成细胞
$ _0 } a0 a# l5 \: ]4 s
CGD:chronic granulomatous disease,慢性肉芽肿病
6 X* O9 ^6 o! U( ]9 q6 O
CGP:circulating granulocyte pool,循环粒细胞池
& y2 X+ Z/ S4 E
cGVHD:chronic graft versus host disease,慢性移植物抗宿主病
1 l. x G. ^' |: `: N7 c6 D
Chemo-responsive:化疗敏感的
s# ~$ I4 {) ~7 h7 t
Chemotherapy:化学疗法
3 m" N5 P+ H& u* r& {/ ]9 W
Chronic慢性的
, d* X- E; E2 W* s: e
C.I.:continuous infusion,持续静脉点滴
1 g6 T! z1 ?3 N. R3 c
CIK:cytokine-induced killer cells 细胞因子诱导的杀伤细胞
F& V9 ?4 m: J6 H& }9 B
CliniMACS:clinical magnetic activated cell sorting,临床级磁性活化细胞分选系统
# `: E1 S4 o4 E2 U9 B- V, U
CLL:chronic lymphocytic leukemia,慢性淋巴细胞白血病
+ ^: X! P4 x5 k# }, k5 G& f( A
CML:chronic myelogenous leukemia,慢性粒细胞白血病
' P5 F; L$ y8 ^/ c- a
CML-AP:CML-accelerated phase,慢性粒细胞白血病加速期
% b% o) M6 C. q9 Z& D- e
CML-BP:CML-blastic phase,慢性粒细胞白血病急变期
0 u4 f( B8 `4 S; z
CML-CP:CML-chronic phase,慢性粒细胞白血病慢性期
. b8 B, }/ R2 x6 F3 e9 k* x
CMML:chronic myelo-monocytic leukemia,慢性粒-单细胞白血病
8 s) w7 J/ S9 b! }
CMPD:chronic myeloproliferative disease,慢性骨髓增生性疾病
4 q: v, U1 q, c
CMV:cytomegalovirus,巨细胞病毒
4 r9 }. A) ^4 P f( i7 v
CNR:cytokine negative response cell,细胞因子不反应细胞
9 C" p. U8 d6 N* Y! a. X. u( {) h
CNS:central nervous system,中枢神经系统
$ ~5 `: V( O* i" C. p
CNSL:central nervous system leukemia,中枢神经系统白血病
- ?; Z. {( t9 i6 j
Collection: 采集
% K! P+ G6 P" k( w7 _' d$ G0 R
Colony stimulating factor:集落刺激因子
+ r9 t/ Q; s3 I2 _
c-onc:cellular oncogene,细胞癌基因
, P* s0 A" w: B- r
Conditioning:预处理
/ H- D1 g& l6 Z8 c E
Conjunctivitis:结膜炎
1 l, Z, i7 T7 P+ B) V
Convalescence:恢复,恢复期
( u8 ^9 _6 P7 f, G2 F
CP:cancer procoagulant,癌性促凝物质
3 M& h, a) K$ F4 k- P3 G
CPD:citrate phosphate dextrose,枸橼酸盐-磷酸盐-葡萄糖
; a9 f, q: U9 Z Z- G
CPDA: citrate phosphate dextrose adenine,枸橼酸盐-磷酸盐-葡萄糖-腺嘌呤
7 ~$ n; x8 P' r" s$ v7 T4 g
Cpmax:peak concentration,峰浓度
1 I( K7 o/ b- D+ i% C0 |& p8 B; N
CPT:camptothecine,喜树碱
' J: g5 Q. p4 E' I
CR:complete remission,完全缓解
) y ]$ {* K m0 ^, | O5 ^# Q
CRABP:cytoplasmic retinoic acid binding protein,胞浆维甲酸结合蛋白
5 e E& ` V% |# z; {5 H* h
CRP:C reaction protein,丙反应蛋白
1 ?/ F% ?' j2 l- Y: F' I. y* X, }
CRR:complete remission rate,完全缓解率
0 L( Z, i: k4 `( t5 f4 e
Cryopreservation:冷冻保存,深低温保藏
3 a' @, y r# a+ g2 ]8 y) T
CSF:colony stimulating factor,集落刺激因子
1 j& L% R) }# D$ c" k8 P( O% w
CSF:cerebrospinal fluid,脑脊液
5 A+ T$ t4 H. T9 m5 Y: j
CTCL:cutaneous T cell lymphoma,皮肤T细胞淋巴瘤
% e E7 {1 C6 w, k9 l" ^' @
CTCL:central T cell lymphoma,中枢T细胞淋巴瘤
' ^9 P) x o: d7 @ C
CTL:cytotoxicity T lymphocyte,细胞毒性T淋巴细胞
1 A8 E A7 m# r. z0 a* Z
Cyclin:周期素
( z* u5 {4 ~0 h/ R5 C- o0 q& i
Cytomegalovirus:巨细胞病毒
/ F) q/ m, o* F* s2 \4 W
DC:dendric cell,树突细胞
! C. r! P& A+ e+ l# [* y
D-D:D dimer,D-二聚体
+ Q5 ]) ]" ^' i
Del:deletion,缺失
: x0 t6 M8 n( h6 J$ ~2 n. P
Dermatitis:皮炎
8 J/ k& x- g9 F
De nova AML:非继发性急性髓性白血病
% O/ h/ J0 p( _9 U9 T; F L- k& O
DFS:disease free survival,无病生存期
0 y0 o7 r6 g4 i* `8 B- w
DI:DNA index,DNA 指数
c0 |' G1 `1 V1 M! A6 O. z( @. X
DIC:disseminated intravascular coagulation,播散性血管内凝血
( s* n1 x9 @" n4 R: c. G2 z
Dilution:稀释
9 u# t8 L3 D9 Y9 w
DL:discordant lymphoma,混杂型淋巴瘤
7 K) f3 j P; k2 j6 a
Donor:供者
5 y: K7 n) D; H6 n! l q& q1 ]( O
Dysplasia:发育不良,发育异常
+ n0 L4 C N) O
EBV:Epstein-Barr virus,EB病毒
6 W8 b! `2 O4 c; b1 z- U5 h0 s1 o& ~- }
ECM:extracellular matrix,细胞外基质
- S( G! G* ~& ?' \ n
-ectomy:(后缀)(外科)切除,除去,去掉
2 X5 d( p% Y: |$ g- m1 G
Edema:水肿
& x8 c0 g( T& F% s& L
EGF:epithelial growth factor,表皮生长因子
q7 Z, n p, s+ p$ u
-emia:(后缀)血液疾病
8 t: A+ X* ^4 |1 R0 l( e9 Y5 B
Encephalopathy:脑病
* I! Q" e) e+ K+ L, |: D& d
Encode: 编码
: h/ B% i% f( n9 f! ]. u0 |
Engraftment:移植物植入
4 w+ Q; I: Z1 g$ R
Enrich:富集
3 Q- \7 F; J! H0 l
Enzyme:酶
, c2 W% y" t. n% |- o
Eosinophil:嗜酸性粒细胞
7 _( d& k8 k, S! I4 b0 Y& L! R+ o
EPO:erythropoietin,促红素,红细胞生成素
/ y4 d% A) k- J- d
ETT:essential thrombocythemia,原发性血小板增多症
) ~, \. k. N( h" C
Ex vivo:体外
$ R' ]7 Z6 h( S+ r" I2 x
FACS:fluorescence activated cell sorting,荧光活化细胞分选系统
1 y# A4 ~" k) ?3 N! }
FCM:flow cytometry,流式细胞分析技术
+ g. A F9 b8 a# n
FDC:follicular dendritic cells,滤泡树突状细胞
' e9 U% ^4 U% m' [7 n4 A
FDGF:fibroblast derived growth factor,成纤维细胞源生长因子
/ x, g$ r/ G$ Z# P- _3 [
Febrile:发热的
4 r* G B+ K/ I1 L8 d* A' W: }/ j* g
FFP:fresh frozen plasma,新鲜冰冻血浆
! ?6 B0 i( H+ ]+ g9 h
FGF:fibroblast growth factor,成纤维细胞生长因子
/ R' z C. u, q" `1 B& y
FHH:familial hemophagocytic histiocytosis,家族性嗜血组织细胞增生症
; I _* n$ p; G; c, Q
FISH:fluorescence in situ hybridization,荧光原位杂交
6 _; z3 x: B9 d* [7 Q; u, j. w& Z
FMF:familial Mediteranean fever,家族性地中海热
5 X. v2 W6 D' f" v2 q
Foley catheter:弗利氏导尿管,气囊导尿管
3 s1 v% D0 [& p" B' g
FrTBI:fractional total body irradiation,分次全身照射
1 ?3 X$ H L3 B& E9 W) b
FSRC: 胎羊体内增殖的人造血干细胞
0 l- ?! Q9 Q& y/ B
Fungus:真菌
. D/ B5 t& s' B2 x* O6 L, g
Fungi: Fungus复数形式
9 `+ C8 S) T' d* l4 `
G6PD:glucise-6-phosphate dehydrogenase,6-磷酸葡萄糖脱氢酶
' Z! t( E( Y! s( P" n- A
Gastritis:胃炎
) D, z( K1 ?* ~( F) _6 m
Gastrointestinal:胃肠道的
2 y0 c2 h5 M5 E3 T& I' x/ R
G-CFC:granulocyte colony forming cells,粒细胞集落形成细胞
; T' ^& `6 f, |" [; E* a
G-CSF:granulocyte colony stimulating factor,粒细胞集落刺激因子
$ [( P. m! d3 m) q4 {& V! i
GCV:cytomegalovirus,巨细胞病毒
8 x. e' D5 ]: A W' p# t
GCV:ganciclovir,更昔洛韦
& T% ?' E5 N) [
GI:gastrointestinal,胃肠道的
9 W. ~* h9 L4 Y1 t. v
GM-CSF:granulocyte-macrophage colony stimulating factor,粒-巨噬细胞集落刺激因子
, E- Y+ x: P4 y" Z" q
GM-CFC:granulocyte-macrophage colony forming cells,粒-巨噬细胞集落形成细胞
+ A' W5 |3 M- l
Graft rejection:移植排斥(反应)
0 c X# z ]$ P$ h9 Q8 w8 E
Graft-versus-host disease:移植物抗宿主病
2 y2 h* y% q0 y3 u: y# D$ D
Granulocyte:粒细胞
6 L& q- V' S3 p. G+ ]5 i0 o/ u
Growth factor:生长因子
: R. d8 k; b0 F3 d* c5 F Q
GTR:granulocyte turnover rate,粒细胞转换率
* n' V2 r \& ~6 J$ `
GVHD:graft-versus-host disease,移植物抗宿主病
' T5 v9 W0 L4 F' ]
GVHR: graft-versus-host reaction,移植物抗宿主反应
4 F8 W* ^& m8 Q+ F1 E2 H
GVL:graft-versus-leukemia,移植物抗白血病
2 }" j( s- `4 C
GVT:graft-versus-tumor,移植物抗肿瘤
8 ^& W& l0 G Q9 M
Haploidentical: 半相和的
3 L4 `- n r; G. x9 G7 [
Harvest: 收集,采集
2 c- |5 ^; @! X) x3 E
HC:hemorrhagic cystitis,出血性膀胱炎
) v5 j" f# h$ q; {# S7 o
HCL:hairy cell leukemia,毛细胞白血病
t8 g% f4 o' J* [3 b6 r4 i
HD:Hodgkin's disease,霍奇金病
0 S* U$ q: G+ K
HD:high dose,大剂量
. w6 T/ Z1 m1 M' E O2 @
Hematocrit:红细胞压积
7 {6 A, i7 i* g4 k3 k. W0 j9 U
Hematology:血液学
7 h0 r! A! v# e, W
Hematopoiesis:造血作用,生血作用
" r, |5 a5 a5 o! r
Hematopoietic system:造血系统
# x( M n* s% a: w# j2 @; j
Hemoglobin:血色素,血红蛋白
- w* z% {& I4 D$ z4 g
Hemorrhage:出血
6 t$ K+ F# u+ s5 X# d
Hemorrhagic cystitis:出血性膀胱炎
9 A. R6 d" m# M A
Hepat - :(前缀)肝的
# W8 B1 I$ x9 X7 L3 a; Y
Hepatitis:肝炎
( F8 `. U, Q f" S! d0 a
HES:hypereosinophilic syndrome,高嗜酸粒细胞综合征
5 h' f4 ~) j7 q4 l! D% h, E9 s2 g
HGF:hematopoietic growth factor,造血生长因子
6 Z U' d, s0 J8 ?# B: x9 N
HHV:human herpus virus,人疱疹病毒
8 H1 t0 Q |) q$ M
Hickman catheter:Hichman导管,中心静脉插管
2 } ^6 Z4 g! U4 @, T/ Z [
HIV:human immune deficiency virus,人免疫缺陷病毒
8 {+ A8 Z8 j: r/ h% M3 m: D
HLA:human leukocyte antigen,人类白细胞抗原
0 j( C# ]: Y4 E! p5 l
HLH:hemophagocytic lymphohistiocytosis,嗜血细胞性淋巴组织细胞增生症
' ~; D0 F `1 B2 I
HMR:histiocytic medullary reticulosis,组织细胞性髓性网状细胞增生症
' ~+ [/ l' `8 F" q) Q8 J
Homogenic transplantation:同基因移植
! W. N6 x* e" N+ J$ `: \- x
Homozygote:纯合子
. M8 r6 t3 n# Q5 ~1 s
HPC:hematopoietic progenitor cell,造血祖细胞
& U5 v6 V, ]0 t3 M3 E+ m( N
HPP-CFU:high proliferative potential colony-forming unit,高增殖潜能集落形成单位
8 a# f% E/ V8 h( I
HR-ALL:high risk ALL,高危型急性淋巴细胞白血病
4 j& ^% X/ o7 `, T1 X+ U
HSC:Hand-Schuller-Christian disease,韩-薛-柯病
9 ?: p0 |+ M, v& ^; B3 J! C( M
HSC:hematopoietic stem cell,造血干细胞
6 w) O; P1 Q0 w' a3 h& w1 H
HSR:homogenously staining region,均染色区
% ~0 t ] _9 ?* i) D N! U5 M! i
HSV:herpes simplex virus,单纯疱疹病毒
* L# t% N: S+ q* \
HTC: typing cell,纯合子分型细胞
J, K. ?" T1 t& s
HTLV:human T cell leukemia virus,人类T细胞白血病病毒
8 m* r- n! ~6 T2 J4 e
HVOD:hepatic venous occlusive disease,肝静脉闭塞病
l3 o! v: h; ?: o; I3 X% k- O2 b
Hyper- :(前缀)高,超,(过)多
8 P9 v# t" f/ T, d
Hyperalimentation:高营养支持,静脉高营养
6 e% @% N0 b" L4 z
Hyperpigmentation:色素沉着过度
+ i( Q8 L6 a9 A$ P7 |, h; x: x
Hypertension:高血压
# x, Z/ F* T+ L, Y
Hypo- :(前缀)(过)低,少于
# G7 g5 p9 i# H# ~
Hypotension:低血压
$ g5 i3 V0 ? _( U. N
IAHS: infectous-associated hemophagocytic syndrome,感染相关嗜血细胞综合征
/ q: z: s+ p. z
id:medium dose,中剂量
0 X1 V0 k, ?6 [2 z) j( _
id:initial dose,初始剂量
0 {( P: g- P' w( u; ]- H% V1 r' K6 {" V
IF:involved field,累及野
0 B' L+ ^' n& A' ]( K: [, Z' [
IFN:interferon,干扰素
( Q V! v; G) g/ n. i5 j+ |
Ig:immunoglobulin,免疫球蛋白
8 G- k$ @' W) J! Z' ]* E
IGFs: insulin-like growth factor,胰岛素样生长因子
]; K) O- X. F; Q
IgH:immunoglobulin heavy chain,免疫球蛋白重链
9 m* ~% ~6 ]4 ~: ] W l
IL:interleukin,白细胞介素
U. o. R k: ]3 ] d0 m5 w/ b
Iliac crest:髂嵴
w8 c. X% B" s/ R( }" x
I.M.:intramuscular,肌肉注射
- ?( g. `$ h0 _# p
Immune system:免疫系统
7 I; d% z" w$ O G3 |0 {- K3 `
Immunocompromised:免疫受损的
/ {# W6 j4 _+ w# s! N) ?* h7 s
Immunoglobulin:免疫球蛋白
2 k& _+ {4 O8 Q, m! y
Immunological tolerance:免疫耐受
. [+ C+ z* |# G% U) R5 [8 a
Immunosuppression:免疫抑制
8 N$ m5 P: C0 |- S2 C
Incubation:孵育
# ~% S+ T! G; \. T
informed-consent:知情同意
' G, U( Z) N9 e1 I; J
Intravenous:静脉内的
, s- L5 t$ F% L$ M2 j5 o
inv: inversion,倒位
* j8 {6 n& E/ F$ _: `9 c
in vitro: 体外,离体
8 a/ _# ^; u, K- N% S; O2 @* l, c. U
in vivo: 体内
7 h7 H# m/ q! Q: W
IP:interstitial pneumonia,间质性肺炎
; j' n( q: w6 h4 w. [8 {
Isolation: 分离
' n4 }! H7 ?7 l0 I) h
I.T.:intrathecal injection,鞘内注射
1 K }' m( s; k$ r5 \/ Z
-itis:(后缀)炎症
) s9 z" H0 v& Y3 }1 L
ITP:idiopathic thrombocytopenia purpura,特发性血小板减少性紫癜
2 K$ W3 | E: W U' _
Jaundice:黄疸
" t3 I% ^9 ]; ^2 d
KPS:Karnofsky score, Karnofsky评分
2 p, \* ^! M& b- c- k
LAK:lymphokine-activated killer(cells),淋巴因子激活杀伤(细胞)
" F( e$ V* }: M3 d
Laminar air flow unit:层流间
% n2 \ O4 w9 c! ?' _- ~- x6 b
LCH:Langerhans cell histiocytosis,郎格罕细胞(组织细胞)增生症
3 P4 P$ r& R: [! U
LD:lymphocyte depletion,淋巴细胞消减型
+ [5 H5 Z0 n! U8 W1 x1 O) n
LD:low dose,小剂量
- Q- y. O2 D) a" K$ {
LDH:lactate dehydrogenase,乳酸脱氢酶
9 Q0 d- I2 n+ d l
Leukapheresis: 白细胞采集物
4 x; |1 [' K7 z
Leukemia:白血病
" K D+ v1 B7 U+ l, K2 B
Leukocyte:白细胞
7 M9 _* k2 H) H y6 [8 U, r% J( C
Leukopenia: 白细胞减少症
% y4 }* ~# ^" `2 V4 g, s
LFA:lymphocyte function associated antigen,淋巴细胞功能相关抗原
8 B, _6 R: U, P @$ F
LFS:leukemia free survival,无白血病存活期
2 Q2 u" Q) ]+ T m- S
LGL:low grade lymphoma,低度恶性淋巴瘤
- e8 ~8 Q! {" v6 F4 N7 K9 C' C
LHR:lymphocytic homing function receptor, 淋巴细胞归家功能受体
5 _* o9 m+ B8 V! ^/ {: c/ i# k2 w
LI:labeling index,标记指数
: H7 |5 I3 j8 r3 V7 ?
LIF:leukemia inhibition factor,白血病抑制因子
2 D0 }5 d+ @4 i( T6 { r
Lineage:系
/ ]( n# |) ^; m8 q
LOH:loss of heterozygosity,杂合性丢失
5 `4 @. F, O8 U# ~9 s6 g0 H$ i
LP:lymphocyte predominance,淋巴细胞为主型
' U7 c) e* Z4 n9 X
LRP:lung resistance related protein,肺抗性相关蛋白
, j& ~/ C% f- B, a, p9 u7 `
LTB:life-threatening bleeding,致命性出血
) E. k5 ?/ S9 x2 m: i
LTC-IC:long-term culture-initiating cell,长期培养起始细胞
$ j6 t7 T3 W% w/ @1 @
LTR:long terminal repeat:长末端重复序列
4 | n( w3 [) ?4 G$ V1 G! i" I: r
LVL:large volume leukapheresis,大容量白细胞单采
; W; H+ c0 u# ?
Lymphocyte: 淋巴细胞
/ {- [: l; O5 o1 l. \7 ^/ H/ d
Macrophage:巨噬细胞
- J6 Y' [# F* i/ R
MACS:magnetic activated cell sorting,磁性活化细胞分选
2 v2 o& p- F/ [) A6 F# {) M
MAK: monocytokine-activated killer(cells),单核细胞因子激活杀伤(细胞)
3 b! l' I. }+ S- m( b- E9 Q
Malabsorption:吸收障碍
7 G% {- m+ m& z: ]4 {9 v
MALT:mucosa-associated lymphoid tissue,粘膜相关淋巴样组织÷
. B) @/ F3 c9 t, Q+ Q
Matching:配型
A3 X4 @) l" x% F& Q8 C
MBDI:marrow blast decline index骨髓原始细胞减少指数
' t" ~# x4 R+ V( z$ ~% J7 P
MC:mixed cellularity,混合细胞型
. l+ |1 e; H# u3 t) X. N+ o
McAb:monoclonal antibody,单克隆抗体
/ M- M1 r8 i# x4 Q1 c9 e. w i7 ?, A
mCR: median complete remission,中位完全缓解
- v1 P3 Q- S* t4 u# i, v$ `. Q
MDR:multiple drug resistance,多药耐药
' X) e/ s" j. n# `3 G5 S
MDS:myelodysplastic syndrome,骨髓增生异常综合征
; b+ _) X3 B0 _1 x. y
Megakaryocyte:巨核细胞
5 \5 S# T; ]+ U% V
Metabolite:代谢物
* B; h7 k9 Y0 R$ @( f2 j) y6 w- m
Metastatic:转移的
9 Y7 `" o% h w9 h
MF:myelofibrosis,骨髓纤维化
: {5 T! [7 E& U, v" w+ O( I7 d
MF:mycosis fungoides,蕈样霉菌病
, m/ F6 a( d7 i! f! G" k
MGDS:megakaryocyte growth and differentiation factor,巨核细胞增殖分化因子
, h* y( j: _: Q
MGP:marginal granulocyte pool,边缘粒细胞池
- L+ `8 n8 N* k9 G, W) C
MGUS: monoclonal gammopathy of undetermined significance,未定性的单克隆γ球蛋白血症
4 B) u8 h" c' ^# ?6 M8 {
MH:malignant histocytosis,恶性组织细胞增生症
, g$ |' x- P; N
MHAS:minor histocompatibility antigen systems,次要组织相容性抗原系统
- m- s: m8 Q: z3 S; B0 n
MHC:major histocompatibility complex,主要组织相容性抗原复合体
6 p( @- j8 w8 }
MLC:mixed lymphocyte culture,混合淋巴细胞培养
7 [4 |! X/ b! T- C4 A
MLL:mixed lineage leukemia,混合系白血病
% o/ t/ }" ^! ]
MM:multiple myeloma,多发性骨髓瘤
" r5 s- L4 B9 g! C& t. f
MNC:mononuclear cells,单个核细胞
8 v/ C# n g. T! @
Mobilization:动员
! s1 I& d9 U% a% @, e5 t1 U
Monoclonal antibody:单克隆抗体
4 u0 Z, u. B9 ?; @: e" z
Monocyte:单核细胞
! {5 u' @; ~$ P9 Z- I9 s
Monozygotic:单合子的
# `, x, \ }8 _4 c) v
Morbidity:发病率
1 ]0 D6 ^! A: ~! }: k
MPD:myeloproliferative disease, 骨髓增殖性疾病
+ K" {, A5 ?' R5 s
MPO:myeloperoxidase,髓过氧化物酶
1 l) k: C. K% V. l, m+ w! i
MRD:minimal residual disease,微小残留病变
2 t3 ^9 l/ A0 C& }8 F8 v4 ^
MRP:multidrug resistance-associated protein,多药耐药相关蛋白
9 U: r" Q/ S1 l% M7 ^# W8 N
Mucositis:粘膜炎
6 a* X4 W$ q' {0 V/ o: J9 [$ s
MUD:matched unrelated donor,非血缘关系配型相合供体
/ s5 Q2 V7 g" h/ g7 Z+ [5 d
NAP:neutrophil alkaline phosphatase,中性粒细胞碱性磷酸酶
9 Q2 o/ z6 P5 ^+ j @, y8 h
NB:neuroblastoma,神经母细胞瘤
+ ?4 k7 O7 J' `2 ~6 Z/ l3 W
NBM:normal bone marrow,正常骨髓
) l- g6 g9 J# q. d) q( j/ K6 x+ L
Negative selection:阴性选择
; E: Z& e& U% g
Neuro- :(前缀)神经的
, `; D- D8 W9 ~* l0 S" o. y$ O
Neutropenia:中性粒细胞减少症
1 f3 J& i2 _% I- x& u, i7 c
Neutrophil:中性粒细胞
R+ X5 \ J+ G2 b! [+ E d
NG:neutrophil granulocyte,中性粒细胞
8 S' S% Z3 }" E6 {2 \
NGF:nerve growth factor, 神经生长因子
9 n) }, O0 c6 `+ V9 b4 L
NHL:non-Hodgkin's lymphoma,非霍奇金淋巴瘤
0 ?1 p d* `1 [5 m, ~( R
NK: nature killer cell,自然杀伤细胞
2 Q; X8 {4 L/ Y: X- O" u0 s
Nonmyeloablative transplantation: 非清髓性移植
8 H7 q3 y( R* `1 M5 Y6 G& r
NPO:不能进食
+ R2 t% F: Q& I8 Z, Z/ p7 q/ p
NS:nodular sclerosis,结节硬化型
0 m1 I$ _7 R4 ?' m
Oncology:肿瘤学
& j; E( k+ R/ K8 k, d
Oto- :(前缀)耳的
8 l) _% M. u6 X) ]. Z( S
PA:plasminogen activator,纤溶酶原激活物
8 \% ~; Q" \( u6 q; Y. z+ ~( [5 o
Packed red blood cells: 压积红细胞
4 z! m3 Q8 `" p3 b
PAE:post antibiotic effects,抗生素后续作用
A9 t. _1 N: _% i& V
PAI:plasminogen activator inhibitor,纤溶酶原激活物抑制剂
% L7 N$ T# J8 o$ h% i& d
Palliative:减轻的,缓解的
q- g( Y/ T4 K7 d- N
palliative care unit (PCU):终末期病房,临终关怀病房
6 K. q5 Y4 A1 A( C3 k7 t
Pancytopenia:全血细胞减少症
; I/ N g* M% Z1 h+ i$ d* O& N
-pathy:(后缀)病
, x3 y; _3 y Y+ w3 m
PB:peripheral blood, 外周血
7 v2 r8 u0 z8 h9 X
PBL:peripheral blood lymphocyte,外周血淋巴细胞
@" W( I3 I* v) ~: O8 |
PBPC:peripheral blood progenitor cell,外周血祖细胞
: G F/ w0 F. w0 x% P' L
PBSCT:peripheral blood stem cell transplantation,外周血干细胞移植
) c k, |: W# k1 ]: z
PCA:procoagulant activity,促凝活性物质
# k8 a7 \( Z5 {& B" w. O; j3 |# y8 _
PCD:programmed cell death,细胞程序化死亡
' z* N& [6 k+ e
PCL:plasma cell leukemia,浆细胞白血病
, r* L- B, E" L4 n9 L+ ]3 O
PCLI:plasma cell label index,浆细胞标记指数
# J. B! ^4 C2 J A7 p: |* a2 b
PCR:polymerase chain reaction, 多聚酶链反应
; J+ C7 P ^9 V* R4 ^; _
PCR-RFLP: PCR-restriction fragment length polymorphisms,限制性片段长度多态性分析
9 g4 n. S& E" c/ h
PCR-SSOPH: PCR-sequence specific oligonucleotideprobe hybridization,序列特异性寡核苷酸探针杂交
! W( w& m" V( o1 U K) d! @
PDD:percentage depth dosage,百分深度剂量
; x% t% I9 V5 y" S/ [" s
PDGF:platelet derived growth factor,血小板衍生生长因子
, Z3 H' g1 f9 r+ U/ C. R
PDR:primary drug resistance,原药耐药
4 @. `& H; C) ^# {3 w/ G4 G2 M! S; y" x
PE:plasma exchange,血浆置换
9 L+ k7 Y) C6 j" [) D
-penia:(后缀)缺乏,不足
# L; s' V* V: k- {8 A% g1 A
Peripheral neuropathy:周围神经病变
5 |+ s' _3 P' l# v; t2 i: f
Petechiae:瘀点,瘀斑
5 r, K7 l* m/ d( G
Pfu: plaque forming unit,空斑形成单位
$ N- E3 e9 M$ R% U
PHA:phytahematoagglutinin,植物血凝素
; S' N" R1 v/ g& D9 }2 W
Phlebitis:静脉炎
+ x @& \4 t, W; \
PHSC:pluripotential hematopoietic stem cell,多能造血干细胞
& X( e- _& s; ^
-plasia:(后缀)发展,形成
% q2 L5 h4 e1 T
Plasma:血浆
% v! `8 j. z( q k
Plasma cell: 浆细胞
8 L. c) e0 x( {
Platelet:血小板
" P3 t! c4 \) l& Y& Q J! ]9 M
PLG:plasminogen,纤溶酶原
4 v! ^$ p' u. V
PLL:prolymphocytic leukemia,幼淋巴细胞白血病
, i0 s+ s. D5 {2 a1 V
PLT:platelet,血小板
n- s9 f+ h' p$ x" P
PLT:primed lymphocyte test,预致敏淋巴细胞试验
4 s0 \( \+ M, R1 ^" D0 V, \
PMN:polymorphonuclear leukocyte,多形核白细胞
7 z4 @# y8 D3 B$ Z9 ~' {
PNH:paroxysmal nocturnal hemoglobinuria,阵发性睡眠性血红蛋白尿÷
' S* D* z+ C/ e& Y' [, ?! G( @
PNRE:p53 negative response element,p53阴性反应元件
: ~" ]' I0 s" ]( O0 {0 j% D) E+ I
POD:PML oncogenic domain,PML癌基因结构域
. Z( ~2 \1 Z+ }/ S
Polycythemia:红细胞增多症
7 X Q$ I( M, x8 n
Positive selection:阳性选择
, a9 V5 q* Z3 B2 U- } y/ ~
PPSC: pluripotent hemotopoietic stem cell,全能造血干细胞
9 V7 q* |9 G+ y3 Q
Preparative regimen:预处理方案
, f' l f% g( ?' W4 h
Progenitor:前体,祖先
. S5 O+ \) j: E$ y! b6 f
Prognosis:预后
, ^( d# B5 k7 | ^! P; ?# X+ Z$ A
Prophylactic:adj.预防的;n. 预防性,预防药
: q& s0 f- E2 d: W0 w
Prophylaxis:预防法,预防
( S _$ @0 b/ f1 h$ r/ U
Protocol:草案,协议,治疗方案
& @2 O3 q9 |6 X* ~; b
Proto-onc: proto-oncogene,原癌基因
+ j$ v: H6 u+ F( }
PSS:posterior superior spine,髂后上棘
) }5 p5 Z/ f; e P+ }
PT:prothrombin time,凝血酶原时间
8 Y: Z, a/ v' A9 l. a) X& T8 @3 y" \
PTCL:peripheral T celll lymphoma,外周T细胞型淋巴瘤
0 n' N0 P; Q H: S# h3 r3 D
PTH:post-transfusion hepatitis, 输血后肝炎
8 l5 y5 I. N* r
Pulmonary:肺的
% n0 y0 Q/ P6 r& ?* k: @+ h4 A
Purging:净化
: s! D5 d! [! T
Purity:纯度
. D% }$ \- b: m3 K. e
PV:polycythemia vera,真性红细胞增多症
# e, @$ d8 h2 N: @! A& ]' K8 V% B
Quality of Life (QOL):生活质量
$ ~+ e3 S( ^$ N" R# C, s
RA:refractory anemia,难治性贫血
7 m: X' t' e+ k J+ f! z9 \
RAEB:refractory anemia with excessive blasts,难治性贫血伴原始细胞增多型
8 A4 t0 O# }$ _! d( c
RAEB-T:refractory anemia with excessive blasts,transformation,难治性贫血伴原始细胞增多转化型
8 p, h3 @, ]5 i) m
RAR:retinoic acid receptor,维甲酸受体
6 i9 o) j1 n4 l5 V$ j( H) [0 {; O
RAS:refractory anemia with sideroblasts,难治性贫血伴环状铁粒幼细胞增多
8 S, J( L( T1 Y( ~
RAS:retinoic acid syndrome,维甲酸综合征
' V) N! s" z& T1 A( |, L% |+ ]4 i
RB:retinoblastoma,视网膜母细胞瘤
5 C. K* I& U; }% r. y; Y7 d; s
RBC: red blood cell,红细胞
7 R) U: s$ a, _4 s5 s- j$ v. \( L% r
Reagent:试剂
* P$ U4 Z1 Q9 ]) e' z8 V( d
Recipient:受者
# g8 b( w; v% z" F; m' B+ D
Rejection:排斥
9 c$ M: b+ x7 T* w
Relapse:复发
/ ]) ^; \: z0 n1 C& s! _% z. L
Remission:缓解
. Z6 U5 c; T& o L
Renal:肾脏的,肾的
T. d Y# A7 x# z& }
RFS:replase free survival,无复发生存
0 v# O7 |2 w* J! A; Q$ o
RPC:radiation protective competence, 辐射保护能力
4 u& ?1 ]. w' D4 H: E9 p( a
Regimen-related toxicity (RRT):预处理相关毒性
+ V$ e6 u; i0 w5 X: f
RT-PCR:reverse transcription polymerase chain reaction, 逆转录多聚酶链反应
2 l$ H* l% V0 F6 g1 d
SBB:sudan black B,苏丹黑B
3 D5 c( L, U: \. O, s
SCE:sister chromatial exchange,姐妹染色单体交换
* {9 F+ F4 a; X; @* [0 e# E
SCF:stem cell factor,干细胞因子
8 @7 P; m* f+ d3 ]7 Q2 s: `
SCid:severe combined immunodeficiency disease,重症联合免疫缺陷
. v5 j0 H" A! |
SCL:stem cell leukemia,干细胞白血病
, w& ?) D0 P* P2 i6 I
SE:specific estarase,特异性酯酶
) A/ y: M, M& z% e( [' G/ g/ f
Selectin:选择素
3 G* E2 ~# a6 I2 {" p9 s
Sense primer:同义引物
) ]! l, D9 q, ?
Separation:(细胞)分选
) m# O0 D! u9 t( _; W
Sepsis:脓血病,败血病
9 b7 r% p0 U4 E6 p3 e3 u: C" X O6 `
Sequencing测序
3 y: ~) [8 u+ e& a' T; |
SF:serum ferritin,血清铁蛋白
8 x, o' |2 n' v5 Q+ F
SHML:sinus histocytosis with massive lymphadenopathy,窦性组织细胞增生症伴块状淋巴结肿大
; _: f3 ?% |6 d
SIA:stroma-support immunocytometric assay,基质支持免疫细胞流式细胞仪技术法
1 t- b8 N: f# Q% q; X- n' m7 e6 S$ b
SLE:systemic lupus erythematosus,系统性红斑狼疮
- C* @* }- D: r. S( V% y0 I( r
SLL:small lymphocytic lymphoma,小淋巴细胞淋巴瘤
7 D6 D! S, _! e- w3 g! X
Solid tumor:实体瘤
6 t4 {9 e! b; @ w2 l) ?, H
SR-ALL:standard risk acute lymphocytic leukemia,标危型急性淋巴细胞白血病
6 Q& w5 t$ y" q3 x. F
SRC:SCid/NOD小鼠体内增殖的人造血干细胞,SCid造血重建细胞
- q( Y; U/ Z. w g p
SS:Sezary syndrome,Sezary综合征
/ _8 N% z8 P) l# h
Stem cell:干细胞
; g, N, e* H2 y
STNI:subtotal nodal irradiation,次全淋巴结照射
@$ b' m1 N+ m+ m
Stomatitis:口炎
6 b! X* W9 G, l. H/ ?
Subclavian catheter:锁骨下导管
' u+ }6 k" w$ H7 \) \" n
Supernatant:上清
9 B& m/ ]5 X5 |
Syn-BMT:Syngeneic bone marrow transplant:同基因骨髓移植
& F, K9 Q7 c( ?1 v' r$ e
Syngeneic:同基因的
& b# H& m+ R' x4 ]1 C
TAM:tumor associated macrophage,肿瘤相关巨噬细胞
) l+ T, T6 L4 d# W' K6 z
t-AML:treatment associated AML,治疗相关的急性髓性白血病
/ H& r( o2 E! s
TA-GVHD:transfusion associated graft-versus-host disease,输血相关的移植物抗宿主病
[9 j+ q& _+ P+ a$ C; A! e$ d2 D
TAA:tumor associated antigen,肿瘤相关抗原
, r( K1 b* ~2 x( G# Q8 q
TBGP:total blood granulocyte pool,总血液粒细胞池
% }! j' N& ^0 h$ y
TBI:total body irradiation,全身照射
% i8 T; {+ d4 X2 T& f/ W
Tc:time of cell cycle, 细胞周期时间
$ N9 ]! H( N h! r- j& t
TCD:T cell depletion, T细胞去除
. {3 E7 G+ C# |7 L+ X
TCL:T cell leukemia/lymphoma,T细胞白血病/淋巴瘤
- g7 s1 z# t8 X0 V7 w3 K0 x3 A
TCR:T cell receptor,T细胞受体
! p4 Z5 W ^9 `+ ]* o, ]
TCS:tumor cell survival,肿瘤细胞成活
4 Z5 r9 Q5 ^" R1 j( @) C
TEN:total enteral nutrition,完全胃肠内营养
9 y: B+ v3 j: l* ]& @0 a
TF:tissue factor,组织因子
4 {+ |1 B ?/ p9 T; N
TF:thymic factor,胸腺因子
8 ?0 G* U4 j9 {- T2 i" u
TFPI:tissue factor pathway inhibitor,组织因子途径抑制物
% @$ I/ v4 f v6 _9 l) M5 Q
TGF:therapeutic gain factor,治疗获得系数
+ @. a9 q9 H X3 |7 e
TGF-β:transforming growth factor-β,转化生长因子β
' ^5 ?- B; G3 S+ L
Thrombocyte:血小板
3 k- }2 h" G" ?2 v% N/ W
Thrombocytopenia:血小板减少症
, k, s& j% q, q: i
TIL:tumor infiltrate lymphocyte,肿瘤浸润淋巴细胞
# X' o% Z6 r; \9 ^& Z0 p3 U" p2 H
TL:testis leukemia睾丸白血病
4 ?5 I" i9 x P; n) S; J0 d
TLI:total Lymphoid irradiation,全淋巴照射
& o9 i# G" j! g5 K
Thrombotic microangiopathy (TMA):血栓性微血管病
& p$ c! |" M0 ^
TNF:tumor necrosis factor,肿瘤坏死因子
# t5 a9 ~7 ?% r {
TNI:total nodal irradiation,全淋巴结照射
% [. h( W! y$ l8 ~9 `& L. H
TOPO II:topoisomerase II,拓扑易构酶II
% J1 |7 s# S( K: o: m
Toxin:毒素
8 T, b% W& V) P( a
Tpdt:potential doubling time,倍增时间
& W3 @- M* f. W; ~
T-PLL:T-prolymphocytic leukemia,T幼淋细胞白血病
! h7 ~& x( h8 k3 v
TPN:total parenteral nutrition,全肠道外营养,静脉高营养
( J# A! z2 I5 s1 J A' T
TPO:thrombopoietin,促血小板生成素
: E$ f: V+ ?: V. Y0 o' G3 k' c- E
TPS:treatment planning system,治疗计划系统
$ I4 Y# T# @# N3 J" G2 r
Translocation:易位
: J/ q9 N& g2 }8 N; c
Trauma:创伤
+ B" w0 l! m- P1 P! `9 d5 F
TRM:transplantation related mortality,移植相关死亡率
0 Q; k3 i6 ]0 q5 q
TSC:timed-sequential chemotherapy,时相序贯化疗
/ J/ M: S' _% z: p9 e' G
TSPA:triophosphoramide,噻替派
m) K, d$ }1 H7 D' [( n
TTP:thrombotic thrombocytopenic purpura,血栓性血小板减少性紫癜
" y1 l/ f8 I5 n1 e$ O( Q: s
Tumor:肿瘤
+ a. T2 P f3 Z% j2 u- ]
Tumor burden:肿瘤负荷
9 @# l# h: p1 P5 A2 b; Y
UCB:umbilical cord blood,脐带血
: A( i! P; s6 ]6 n
Ultrasound:超声
4 n0 Z% @4 i$ Q+ y8 Q# p
Umbilical cord:脐带
5 u) M7 {8 ~2 \% U; X
VAHS:viral associated hemophagocytic syndrome,病毒相关嗜血细胞综合征
! I/ r4 E" f$ i+ |* I L3 U
VGPR:very good partial remission,非常良好的部分缓解
( t4 B, @+ ?# E
Viability:活性
' A; Z8 Y \6 }. `7 R* ?" ?; {: T0 A+ c
Virus:病毒
5 A8 S# ^3 o& \
VOD:veno-occlusive disease,静脉阻塞性疾病
2 o" ]( E+ N: }0 k' t
v-onc: virus oncogene,病毒癌基因
; S) n. a( X+ _5 L% d3 m2 G
VPF: vascular permeability factor,血管渗透因子
+ ]: c' M2 b. a0 v7 k! \: H: E
VZV:varicella zoster virus,水痘带状疱疹病毒
- y2 s) u7 m$ ?: s$ J# e7 D
WBC:white blood cell,白细胞
/ X: n" ]( W7 a! {
Whole blood:全血
/ ^3 a/ O* c& r$ }( p; }7 G' [! V
WT:Wilms tumor,肾母细胞瘤
+ T! Z7 Q+ l( [( h1 p7 }
Xerostomia:口腔干燥症
. Z; t C' @* x& }+ A o% o; K ?
Yield:产量
欢迎光临 干细胞之家 - 中国干细胞行业门户第一站 (http://www.stemcell8.cn/)
Powered by Discuz! X1.5